PRIMER SETS
Name |
SKU |
Adenovirus |
|
Anaplasma |
|
Asuragen Internal Process Control |
|
Atopobium vaginae |
|
Babesia |
|
Babesia microti |
|
Bacillus atrophaeus |
|
Borrelia |
BOR001 BOR002 |
Borrelia miyamotoi |
|
BVAB2 |
|
Candida auris |
|
Candida glabrata |
|
Candida krusei |
|
Candida spp |
|
Enterovirus |
|
Ehrlichia |
EHR001 EHR002 |
Gardnerella vaginalis |
|
Group B Streptococcus |
|
HHV-6 |
|
HHV-6A |
|
HHV-6B |
|
HPV Genotype 31 |
|
HPV Genotype 33 |
|
HPV Genotype 45 |
|
HPV Genotype 52 |
|
HSV-1 |
|
HSV-2 |
|
Influenza A H5N1 |
|
Influenza A |
|
Influenza B |
|
JCV |
|
Measles |
|
Megasphaera |
|
Mycoplasma |
|
Parechovirus |
|
Parvovirus |
|
RSV |
|
SARS-CoV-2 |
|
Specimen Diluent |
|
Ureaplasma |
|
VZV |
Controls
Name |
SKU |
Anaplasma Control 1E4 cp/mL |
|
Babesia Control 1E5 cp/mL |
|
Borrelia Control 2E5 cp/mL |
|
Borrelia miyamotoi Control 1E5 cp/mL |
|
Candida auris Control 5E3 cp/mL |
|
Ehrlichia Control 5E4 cp/mL |
|
Influenza A H5N1 Control 1E5 cp/mL |
|
Measles Virus Control 1E5 cp/mL |
|
Stabilized Blood Dilution Matrix |
|
Transport Media Dilution Matrix |
|
Viral Transport Media Dilution Matrix |
*Analytical and performance characteristics are not established.
